ArticleClinical and translational medicine2026
Overcoming the cytosine base editing barrier: Virus-like particles with uracil-DNA glycosylase inhibition unlocking the clinical potential.
Yuqing Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.